Watson Pharmaceuticals Inc



) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 3.6%. By the end of trading, Watson Pharmaceuticals Inc fell $2.67 (-4%) to $64.62 on heavy volume. Throughout the day, 6.2 million shares of Watson Pharmaceuticals Inc exchanged hands as compared to its average daily volume of 1.3 million shares. The stock ranged in price between $63.79-$69.82 after having opened the day at $69.41 as compared to the previous trading day's close of $67.29. Other company's within the Health Care sector that declined today were:

American Caresource Holdings Inc



), down 31.8%,

Poniard Pharmaceuticals Inc



), down 14.4%,

Dehaier Medical Systems



), down 13%, and

Horizon Pharma Inc



), down 12.7%.

Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacturing, marketing, sale, and distribution of brand and off-patent (generic) pharmaceutical products in the United States and internationally. Watson Pharmaceuticals Inc has a market cap of $8.06 billion and is part of the


industry. The company has a P/E ratio of 45.4, above the average drugs industry P/E ratio of 43.4 and above the S&P 500 P/E ratio of 17.7. Shares are up 30.3% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates Watson as a


. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

On the positive front,

PROLOR Biotech Inc



), up 21.4%,

Progenics Pharmaceuticals Inc



), up 20.9%,

Amicus Therapeutics Inc



), up 19.2%, and

Sangamo BioSciences Inc



), up 18.4%, were all gainers within the health care sector with

Abbott Laboratories



) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care